Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interscalene block vs sedation for shoulder dislocation
NCT03041506Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Feb 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in shoulder dislocation, sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Length of stay from beginning of reduction until readiness for dismissal up to 3 hours. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
shoulder dislocation
Beyond the preview
Go deeper on NCT03041506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03041506.